BioVie(BIVI)
1.48 -0.02 -1.3333%
| 今开：1.49 | 昨收：1.5 |
| 最高：1.515 | 最低：1.415 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：1.1151918E7 |
BioVie的热门讨论
年度财报
BioVie(BIVI)08-16 05:15
$BioVie(BIVI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001520138-25-000268 Act: 34 Size: 5 MB 网页链接查看全文
招股信息更正说明
BioVie(BIVI)10-06 18:05
$BioVie(BIVI)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001520138-25-000294 Act: 33 Size: 595 KB 网页链接查看全文
股东委托书协议
BioVie(BIVI)09-26 05:35
$BioVie(BIVI)$ DEF 14A Other definitive proxy statements Accession Number: 0001520138-25-000287 Act: 34 Size: 728 KB 网页链接查看全文
其他
BioVie(BIVI)10-06 18:05
$BioVie(BIVI)$ POS EX Post-effective amendment adding exhibits to registration statement [Rule 462(d)] Accession Number: 0001520138-25-000293 Act: 33 Size: 246 KB 网页链接查看全文
首次持股声明
BioVie(BIVI)10-28 06:45
$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000326 Size: 8 KB 网页链接查看全文
持股变动声明
BioVie(BIVI)08-14 04:15
$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-25-000251 Size: 7 KB 网页链接查看全文
招股说明书
BioVie(BIVI)10-06 18:05
$BioVie(BIVI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001520138-25-000292 Act: 33 Size: 791 KB 网页链接查看全文
首次持股声明
BioVie(BIVI)10-28 23:25
$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000327 Size: 8 KB 网页链接查看全文
当期报告
BioVie(BIVI)08-12 04:35
$BioVie(BIVI)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001520138-25-000249 Act: 34 Size: 1 MB 网页链接查看全文
BioVie的最新讨论
![[滴汗]](https://assets.imedao.com/ugc/images/face/emoji_13_coldsweat.png?v=1 "[滴汗]"){kind=small}
chuminhua2023-11-30 20:57
11/29，BioVie $BioVie(BIVI)$ 的股价周三暴跌 63%，此前该公司报告称，由于某些试验site的问题，评估其实验性阿尔茨海默病治疗药物 NE3107 的 III 期试验的主要终点未能达到统计显著性。 然而，该公司认为，来自可评估患者的数据表明所提议的疗法具有潜在的疗效优势，该疗法是一种结合细胞外信号...查看全文
当期报告
BioVie(BIVI)2023-11-29 21:25
$BioVie(BIVI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001520138-23-000511 Act: 34 Size: 2 MB 网页链接查看全文
当期报告
BioVie(BIVI)2023-11-14 05:35
$BioVie(BIVI)$ 8-K Current report, item 5.07 Accession Number: 0001520138-23-000488 Act: 34 Size: 215 KB 网页链接查看全文
季度财报
BioVie(BIVI)2023-11-09 05:35
$BioVie(BIVI)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001520138-23-000473 Act: 34 Size: 4 MB 网页链接查看全文
当期报告
BioVie(BIVI)2023-10-26 01:15
$BioVie(BIVI)$ 8-K Current report, items 8.01 and 9.01 Accession Number: 0001520138-23-000457 Act: 34 Size: 330 KB 网页链接查看全文
股东委托书协议
BioVie(BIVI)2023-09-30 05:35
$BioVie(BIVI)$ DEF 14A Other definitive proxy statements Accession Number: 0001520138-23-000422 Act: 34 Size: 1 MB 网页链接查看全文
当期报告
BioVie(BIVI)2023-09-11 18:05
$BioVie(BIVI)$ 8-K Current report, items 7.01 and 9.01 Accession Number: 0001520138-23-000375 Act: 34 Size: 11 MB 网页链接查看全文
持股变动声明
BioVie(BIVI)2023-09-08 06:25
$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-23-000371 Size: 4 KB 网页链接查看全文
证券出售报告
BioVie(BIVI)2023-09-06 05:55
$BioVie(BIVI)$ 144 Report of proposed sale of securities Accession Number: 0001950047-23-003728 Act: 33 Size: 4 KB 网页链接查看全文
BioVie的公告
首次持股声明
$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000327 Size: 8 KB 网页链接
首次持股声明
$BioVie(BIVI)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001520138-25-000326 Size: 8 KB 网页链接
招股说明书
$BioVie(BIVI)$ 424B3 Prospectus [Rule 424(b)(3)] Accession Number: 0001520138-25-000292 Act: 33 Size: 791 KB 网页链接
其他
$BioVie(BIVI)$ POS EX Post-effective amendment adding exhibits to registration statement [Rule 462(d)] Accession Number: 0001520138-25-000293 Act: 33 Size: 246 KB 网页链接
招股信息更正说明
$BioVie(BIVI)$ POS AM Post-Effective amendments for registration statement Accession Number: 0001520138-25-000294 Act: 33 Size: 595 KB 网页链接
股东委托书协议
$BioVie(BIVI)$ DEF 14A Other definitive proxy statements Accession Number: 0001520138-25-000287 Act: 34 Size: 728 KB 网页链接
年度财报
$BioVie(BIVI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001520138-25-000268 Act: 34 Size: 5 MB 网页链接
持股变动声明
$BioVie(BIVI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001520138-25-000251 Size: 7 KB 网页链接
当期报告
$BioVie(BIVI)$ 8-K Current report, items 1.01, 3.02, 7.01, and 9.01 Accession Number: 0001520138-25-000249 Act: 34 Size: 1 MB 网页链接
招股说明书
$BioVie(BIVI)$ 424B5 Prospectus [Rule 424(b)(5)] Accession Number: 0001520138-25-000247 Act: 33 Size: 8 MB 网页链接